WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005030982) COORDINATED DECREASE AND INCREASE OF GENE EXPRESSION OF MORE THAN ONE GENE USING TRANSGENIC CONSTRUCTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/030982    International Application No.:    PCT/US2004/031605
Publication Date: 07.04.2005 International Filing Date: 24.09.2004
IPC:
C12N 15/82 (2006.01)
Applicants: MONSANTO TECHNOLOGY LLC [US/US]; 800 N. Lindbergh Boulevard, Mailzone E2NA, St. Louis, MO 63167 (US) (For All Designated States Except US).
VAN EENENNAAM, Alison [AU/US]; (US) (For US Only).
SHEWMAKER, Christine, K. [US/US]; (US) (For US Only)
Inventors: VAN EENENNAAM, Alison; (US).
SHEWMAKER, Christine, K.; (US)
Agent: MARSH, David, R.; Arnold & Porter LLP, Attn: IP Docketing, 555 Twelfth Street, N.W., Washington, DC 20004 (US)
Priority Data:
10/668,240 24.09.2003 US
Title (EN) COORDINATED DECREASE AND INCREASE OF GENE EXPRESSION OF MORE THAN ONE GENE USING TRANSGENIC CONSTRUCTS
(FR) REDUCTION ET AUGMENTATION COORDONNEES DE L'EXPRESSION GENIQUE DE PLUS D'UN GENE UTILISANT DES CONSTRUCTIONS TRANSGENIQUES
Abstract: front page image
(EN)The present invention is directed to nucleic acid molecules and nucleic acid constructs, and other agents associated with simultaneous up- and down-regulation of expression of RNAs. Specifically it includes methods of simultaneously enhancing the expression of a first RNA at the same time as suppressing the expression of a second RNA. The present invention also specifically provides constructs capable of simultaneously enhancing the expression of a first RNA while at the same time suppressing the expression of a second RNA, methods for utilizing such agents and plants containing such agents. The present invention also provides other constructs including polycistronic constructs.
(FR)La présente invention concerne des molécules d'acide nucléique et des constructions d'acide nucléique ainsi que d'autres agents associés à la régulation à la fois positive et négative de l'expression d'ARN. Cette invention concerne spécifiquement des procédés permettant simultanément de renforcer l'expression d'un premier ARN et de supprimer l'expression d'un second ARN. Cette invention concerne également spécifiquement des constructions capables de renforcer l'expression d'un premier ARN tout en supprimant l'expression d'un second ARN, des procédés d'utilisation de ces agents ainsi que des végétaux contenant ces agents. La présente invention concerne en outre d'autres constructions, y compris des constructions polycistroniques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)